News Home » Medical and Pharma » Roche cancer immunotherapy Tecentriq wins EU approval

Around the World

Roche cancer immunotherapy Tecentriq wins EU approval

James Bay 19 September 23
Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.